Evidence map›Paper›PMID 38993523›Full record

ArticleBiology methods & protocols2024

KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution.

Joana Reis de Andrade, Edward Scourfield, Shilpa Lekhraj Peswani-Sajnani, Kate Poulton, Thomas Ap Rees, Paniz Khooshemehri, George Doherty, Stephanie Ong, Iustina-Francisca Ivan, Negin Goudarzi and 29 more

Abstract read
In one paragraph

Article in Biology methods & protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Joana Reis de AndradeResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Edward ScourfieldResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Shilpa Lekhraj Peswani-SajnaniResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Kate PoultonDepartment of Infectious Diseases, King's College London, London, UK.
Thomas Ap ReesResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Paniz KhooshemehriDepartment of Infectious Diseases, King's College London, London, UK.
George DohertyResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Stephanie OngResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Iustina-Francisca IvanResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Negin GoudarziResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Isaac GardinerResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Estelle CaineResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Thomas J A MaguireResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.ORCID https://orcid.org/0000-0003-1034-4926
Daniel LeightleyDepartment of Population Health Sciences, School of Life Course & Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Luis TorricoTorrysoft, Madrid, Spain.
Alex GasullaInnovartium, Barcelona, Spain.
Angel Menendez-VazquezPeter Gorer Department of Immunobiology, King's College London, London, UK.
Ana Maria Ortega-PrietoDepartment of Infectious Diseases, King's College London, London, UK.ORCID https://orcid.org/0000-0002-9023-0103
Suzanne PickeringDepartment of Infectious Diseases, King's College London, London, UK.
Jose M Jimenez-GuardeñoDepartment of Infectious Diseases, King's College London, London, UK.ORCID https://orcid.org/0000-0002-1726-8033
Rahul BatraGuy's and St Thomas' NHS Foundation Trust, London, UK.
Sona RubinchikResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Aaron V F TanResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Amy GriffinResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
David SherrinResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Stelios PapaioannouDepartment of Infectious Diseases, King's College London, London, UK.
Celine TrouilletDepartment of Infectious Diseases, King's College London, London, UK.
Hannah E MischoDepartment of Infectious Diseases, King's College London, London, UK.
Victoriano GiraltArea de Sistemas, Servicio Central de Informática, University of Malaga, Malaga, Spain.
Samantha WilsonResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Martin KirkResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Stuart J D NeilDepartment of Infectious Diseases, King's College London, London, UK.
Rui Pedro GalaoDepartment of Infectious Diseases, King's College London, London, UK.
Jo MartindaleResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Charles CurtisResearch Management and Innovation Directorate, KCL TEST, King's College London, London, UK.
Mark ZuckermanSouth London Specialist Virology Centre, King's College Hospital, London, UK.
Reza RazaviSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.ORCID https://orcid.org/0000-0003-1065-3008
Michael H MalimDepartment of Infectious Diseases, King's College London, London, UK.
Rocio T Martinez-NunezDepartment of Infectious Diseases, King's College London, London, UK.ORCID https://orcid.org/0000-0003-2507-4738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and accessible testing was paramount in the management of the COVID-19 pandemic. Our university established KCL TEST: a SARS-CoV-2 asymptomatic testing programme that enabled sensitive and accessible PCR testing of SARS-CoV-2 RNA in saliva. Here, we describe our learnings and provide our blueprint for launching diagnostic laboratories, particularly in low-resource settings. Between December 2020 and July 2022, we performed 158277 PCRs for our staff, students, and their household contacts, free of charge. Our average turnaround time was 16 h and 37 min from user registration to result delivery. KCL TEST combined open-source automation and in-house non-commercial reagents, which allows for rapid implementation and repurposing. Importantly, our data parallel those of the UK Office for National Statistics, though we detected a lower positive rate and virtually no delta wave. Our observations strongly support regular asymptomatic community testing as an important measure for decreasing outbreaks and providing safe working spaces. Universities can therefore provide agile, resilient, and accurate testing that reflects the infection rate and trend of the general population. Our findings call for the early integration of academic institutions in pandemic preparedness, with capabilities to rapidly deploy highly skilled staff, as well as develop, test, and accommodate efficient low-cost pipelines.

Indexed as

COVID-19diagnosticshealth equitymolecular testingopen-sourcepandemic preparedness

Identifiers

PMID38993523
PMCPMC11238426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.